Who owns Exelixis?

Key details on Exelixis (Ticker: EXEL)

Who owns Exelixis?

Is EXEL a good stock to own? Find out who bought Exelixis, who sold Exelixis (EXEL) stock, and who holds a large position in Exelixis.

Fund Name Number of Shares Share Valuation As Of
Capital Research Global Investors^ 22.57M $138.32M Dec. 31, 2013
Meditor 19.07M $71.70M June 30, 2015
T. Rowe Price Associates 17.71M $45.51M March 31, 2015
Wellington Management Company 16.24M $55.06M June 30, 2014
FMR 15.32M $57.61M June 30, 2015
Vanguard 13.44M $50.52M June 30, 2015
STATE STREET CORPORATION 10.39M $39.06M June 30, 2015
BlackRock Fund Advisors 7.69M $28.92M June 30, 2015
BNP PARIBAS ARBITRAGE, SNC 6.84M $616.42M March 31, 2014
BlackRock Institutional Trust Company, N.A. 5.92M $22.27M June 30, 2015
Dr. Jeffrey R. Jay, M.D. 5.10M $7.80M Sept. 30, 2014
GOLDMAN SACHS 4.49M $16.90M June 30, 2015
Deerfield Management Company 4.00M $10.28M March 31, 2015
SUSQUEHANNA INTERNATIONAL 3.34M $5.12M Sept. 30, 2014
HealthCor Management 3.10M $19.00M Dec. 31, 2013
OrbiMed Advisors 2.89M $10.22M March 31, 2014
Deutsche Bank Aktiengesellschaft 2.79M $8.93M June 30, 2014
BVF 2.77M $10.40M June 30, 2015
Jennison Associates 2.62M $15.24M Sept. 30, 2013
NORTHERN TRUST 2.59M $9.15M March 31, 2014
Balyasny Asset Management 2.41M $3.47M Dec. 31, 2014
Icahn Capital 2.36M $26.64M March 31, 2011